Abstract: The present invention discloses a novel type of highly potent ENPP-1 inhibitors for the treatment of various diseases particularly, cancer. These inventive inhibitors are small molecules. One of the novel structural features is incorporation of a sulfoximine-type moiety which is positioned between the tail and core parts. Method of treatment, pharmaceutical compositions and use thereof are also disclosed.
| # | Name | Date |
|---|---|---|
| 1 | 202547017273-STATEMENT OF UNDERTAKING (FORM 3) [27-02-2025(online)].pdf | 2025-02-27 |
| 2 | 202547017273-REQUEST FOR EXAMINATION (FORM-18) [27-02-2025(online)].pdf | 2025-02-27 |
| 3 | 202547017273-POWER OF AUTHORITY [27-02-2025(online)].pdf | 2025-02-27 |
| 4 | 202547017273-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105-PCT Pamphlet) [27-02-2025(online)].pdf | 2025-02-27 |
| 5 | 202547017273-FORM 18 [27-02-2025(online)].pdf | 2025-02-27 |
| 6 | 202547017273-FORM 1 [27-02-2025(online)].pdf | 2025-02-27 |
| 7 | 202547017273-DECLARATION OF INVENTORSHIP (FORM 5) [27-02-2025(online)].pdf | 2025-02-27 |
| 8 | 202547017273-COMPLETE SPECIFICATION [27-02-2025(online)].pdf | 2025-02-27 |